Nigel McCracken
Directeur des opérations chez VIRAX BIOLABS GROUP LIMITED
Postes actifs de Nigel McCracken
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VIRAX BIOLABS GROUP LIMITED | Directeur des opérations | 01/09/2023 | - |
Historique de carrière de Nigel McCracken
Anciens postes connus de Nigel McCracken
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BERGENBIO ASA | Directeur Technique/Scientifique/R&D | 01/01/2021 | 01/09/2023 |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Directeur/Membre du Conseil | 01/09/2014 | 01/04/2019 |
| Corporate Officer/Principal | 01/09/2014 | 01/04/2019 | |
| NUCANA PLC | Directeur des opérations | - | - |
Formation de Nigel McCracken
| University of Strathclyde | Undergraduate Degree |
| King's College London | Graduate Degree |
Statistiques
Internationale
| Royaume-Uni | 5 |
| Suisse | 2 |
| Norvège | 2 |
Opérationnelle
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BERGENBIO ASA | Health Technology |
| NUCANA PLC | Health Technology |
| VIRAX BIOLABS GROUP LIMITED | Finance |
| Entreprise privées | 1 |
|---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Bourse
- Insiders
- Nigel McCracken
- Expérience
